At a glance
ClinicalIndex Comparison RecordN/AActive· 399 enrolled
Drug / intervention
Shockwave Medical Coronary IVL Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease
In Brief
An observational study evaluating Shockwave Medical Coronary IVL System for Coronary Artery Disease. Active but no longer recruiting, targeting 399 participants across 49 sites in 5 countries.
Detailed Summary
Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesFrance, Germany, Spain, United Kingdom, United States
Collaborators--
Timeline
N/AActive
20242025202620272028
First PostedMar 2023
Enrollment StartMay 2023
Primary CompletionDec 2024
TodayJul 2026
Study CompletionApr 2028
First PostedMar 6, 2023
Enrollment StartMay 3, 2023
Primary CompletionDec 11, 2024
Study CompletionApr 1, 2028
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 3.3 years ago
Interventions
Shockwave Medical Coronary IVL Systemdevice
Coronary Intravascular Lithotripsy (IVL)